Business
New findings by Sri Lankan research scientists highlight the effects of a standardized extract Ceylon Cinnamon on blood sugar
A clinical trial conducted by Sri Lankan researchers has shown that a standardized extract of Ceylon Cinnamon (Cinnamomum zeylanicum), known as CeyCinnXTM, lowers blood sugar levels in patients with Type 2 diabetes mellitus (T2DM).
The study was carried out by researchers from RemediumOne and the Clinical Trials Unit of the University of Kelaniya, in collaboration with Dr. Dimuthu Muthukuda, Consultant Endocrinologist at Sri Jayewardenepura General Hospital. Published in PLoS ONE, the trial is the largest study to date examining the benefits of Ceylon Cinnamon extracts in diabetes management.
Key Findings of the Study
The trial found that participants who consumed a daily dose of the Ceylon Cinnamon extract, CeyCinnXTM, had a reduction in fasting blood sugar over 12 weeks compared to those who did not receive the supplement. While the extract also showed a potential to lower LDL cholesterol (also known as bad cholesterol), this effect was not statistically significant over 12 weeks.